Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR molecules can be transferred from the CAR-T cells to ...
A new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and ...
J.D. Power surveyed more than 80,000 new-car buyers about what tech features they like and dislike. It shows that carmakers are still figuring out what kinds of advanced tech people like—and what bugs ...
In April, the FDA warned of risk of secondary cancers in people receiving CAR-T cell therapy. A large study now finds the risk is low and not related to the CAR-T cells. A large study by researchers ...
The big picture: While Tesla has yet to respond to the iSeeCars report, regulators and consumers will closely watch the company's next moves. As autonomous and semi-autonomous vehicles become more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results